Evidence map›Paper›PMID 26908053›Full record

ArticleScientific reports2016

Polyclonal Antibody Production for Membrane Proteins via Genetic Immunization.

Debra T Hansen, Mark D Robida, Felicia M Craciunescu, Andrey V Loskutov, Katerina Dörner, John-Charles Rodenberry, Xiao Wang, Tien L Olson, Hetal Patel, Petra Fromme and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Debra T HansenCenter for Innovations in Medicine, Biodesign Institute, Arizona State University, Tempe, Arizona, USA.
Mark D RobidaCenter for Innovations in Medicine, Biodesign Institute, Arizona State University, Tempe, Arizona, USA.
Felicia M CraciunescuCenter for Innovations in Medicine, Biodesign Institute, Arizona State University, Tempe, Arizona, USA.
Andrey V LoskutovCenter for Innovations in Medicine, Biodesign Institute, Arizona State University, Tempe, Arizona, USA.
Katerina DörnerSchool of Molecular Sciences (formerly the Department of Chemistry and Biochemistry), Arizona State University, Tempe, Arizona, USA.
John-Charles RodenberryCenter for Innovations in Medicine, Biodesign Institute, Arizona State University, Tempe, Arizona, USA.
Xiao WangCenter for Innovations in Medicine, Biodesign Institute, Arizona State University, Tempe, Arizona, USA.
Tien L OlsonCenter for Innovations in Medicine, Biodesign Institute, Arizona State University, Tempe, Arizona, USA.
Hetal PatelCenter for Innovations in Medicine, Biodesign Institute, Arizona State University, Tempe, Arizona, USA.
Petra FrommeCenter for Applied Structural Discovery, Biodesign Institute, Arizona State University, Tempe, Arizona, USA.
Kathryn F SykesCenter for Innovations in Medicine, Biodesign Institute, Arizona State University, Tempe, Arizona, USA.

Funding

Center for the Rational Design of Membrane Protein CrystallographyU54GM094599 · NIGMS · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI FROMME, PETRA · 2010 to 2014
$6.8M
NIGMS NIH HHS GM094599NIGMS NIH HHS U54 GM094599
6 · The paper itself

Abstract

Antibodies are essential for structural determinations and functional studies of membrane proteins, but antibody generation is limited by the availability of properly-folded and purified antigen. We describe the first application of genetic immunization to a structurally diverse set of membrane proteins to show that immunization of mice with DNA alone produced antibodies against 71% (n = 17) of the bacterial and viral targets. Antibody production correlated with prior reports of target immunogenicity in host organisms, underscoring the efficiency of this DNA-gold micronanoplex approach. To generate each antigen for antibody characterization, we also developed a simple in vitro membrane protein expression and capture method. Antibody specificity was demonstrated upon identifying, for the first time, membrane-directed heterologous expression of the native sequences of the FopA and FTT1525 virulence determinants from the select agent Francisella tularensis SCHU S4. These approaches will accelerate future structural and functional investigations of therapeutically-relevant membrane proteins.

Indexed as

AnimalsAntibodiesAntibody SpecificityAntigens, BacterialBacterial Outer Membrane ProteinsBiolisticsDNA, BacterialFemaleFrancisella tularensisGene Expression RegulationGenetic VectorsGoldGreen Fluorescent ProteinsImmunizationImmunoconjugatesMagnetite NanoparticlesAntibodiesAntigens, BacterialBacterial Outer Membrane ProteinsDNA, BacterialFopA protein, Francisella tularensisGoldGreen Fluorescent ProteinsImmunoconjugatesMagnetite NanoparticlesRecombinant Fusion ProteinsVirulence Factors

Identifiers

PMID26908053
PMCPMC4764931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.